# Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease

> **NCT05957198** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 114921 (actual)

## Conditions studied

- Lung Diseases, Interstitial

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05957198
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-25
- **Primary completion:** 2023-09-26
- **Final completion:** 2023-09-26
- **Target enrollment:** 114921 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05957198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05957198, "Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05957198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*